JP:9434
Market cap
¥9.26T
P/E ratio
21.6x
| Mar 31, 2017 | Mar 31, 2018 | Mar 31, 2019 | Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | |
| Net sales | - | 3,582,635 | 4,656,815 | 4,861,247 | 5,205,537 | 5,690,606 | 5,911,999 |
| Cost of sales | - | 2,040,770 | 2,495,972 | 2,536,837 | 2,701,790 | 2,889,116 | 3,194,085 |
| Gross profit | - | 1,541,865 | 2,160,843 | 2,324,410 | 2,503,747 | 2,801,490 | 2,717,914 |
| Selling, general and administrative expenses | - | 893,522 | 1,339,656 | 1,418,815 | 1,522,975 | 1,858,709 | 1,964,580 |
| Other operating income | - | 4,047 | 8,440 | 12,937 | - | 25,220 | 321,422 |
| Other operating expenses | - | 14,457 | 11,439 | 6,807 | 10,002 | 2,448 | 14,588 |
| Operating profit | - | 637,933 | 818,188 | 911,725 | 970,770 | 985,746 | 1,060,168 |
| Share of profit (loss) of investments accounted for using equity method | - | -3,770 | -6,276 | -46,060 | -45,490 | -60,094 | -47,875 |
| Finance income | - | 2,205 | 2,246 | 2,745 | 5,806 | 39,471 | 11,905 |
| Finance costs | - | 38,814 | 58,023 | 60,921 | 73,369 | 66,442 | 117,212 |
| Gain or loss on sale of equity method investment | - | - | 2,592 | 10,591 | 3,902 | 8,925 | 1,109 |
| Impairment loss on equity method investments | - | - | 12,614 | 6,885 | 13,920 | 29,402 | 45,227 |
| Profit (loss) before tax | - | 597,554 | 746,113 | 811,195 | 847,699 | 880,363 | 862,868 |
| Income tax expense | - | 196,149 | 251,949 | 304,527 | 299,979 | 296,411 | 208,743 |
| Profit | - | 401,405 | 494,164 | 506,668 | 547,720 | 583,952 | 654,125 |
| Owners of parent | - | 400,749 | 462,455 | 473,135 | 491,287 | 517,517 | 531,366 |
| Non-controlling interests | - | 656 | 31,709 | 33,533 | 56,433 | 66,435 | 122,759 |
| Profit | - | 401,405 | 494,164 | 506,668 | 547,720 | 583,952 | 654,125 |
| Basic earnings per share | - | 97.64 | 96.6 | 99.27 | 103.85 | 110.13 | 112.53 |
| Diluted earnings per share | - | 97.63 | 95.91 | 97.94 | 102.66 | 108.27 | 111 |